Inhaled Amikacin for Treatment of Refractory Pulmonary Nontuberculous Mycobacterial Disease

Rationale: Treatment of pulmonary nontuberculous mycobacteria, especially Mycobacterium abscessus, requires prolonged, multidrug regimens with high toxicity and suboptimal efficacy. Options for refractory disease are limited. Objectives: We reviewed the efficacy and toxicity of inhaled amikacin in p...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Olivier, Kenneth N., Shaw, Pamela A., Glaser, Tanya S., Bhattacharyya, Darshana, Fleshner, Michelle, Brewer, Carmen C., Zalewski, Christopher K., Folio, Les R., Siegelman, Jenifer R., Shallom, Shamira, Park, In Kwon, Sampaio, Elizabeth P., Zelazny, Adrian M., Holland, Steven M., Prevots, D. Rebecca
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Thoracic Society 2014
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3972984/
https://ncbi.nlm.nih.gov/pubmed/24460437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201307-231OC
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन